Drugs: From Discovery to Approval - Hardcover

Über die Autorin bzw. den Autor

Rick Ng, PhD, has worked for more than twenty-five years in senior management positions in the private sector pharmaceutical industry. He is currently a director at a biopharmaceutical manufacturing facility in Singapore. He has provided technical training for graduate and postgraduate personnel.

Von der hinteren Coverseite

Praise for the First Edition

"A concise, yet comprehensive, survey of the entire drug development process."
Journal of Chemical Technology and Biotechnology

The new edition of this bestselling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of preclinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs.

This Second Edition features many key enhancements, including Key Points, Chapter Summary, and Review Questions in each chapter; Answers to Review Questions provided in an appendix; and carefully selected "mini" case studies in each chapter.

Richly illustrated throughout with over ninety figures and tables, this important new edition also includes helpful listings of current FDA and European guidelines and a special section on regulatory authority and processes in China. It is an indispensable resource for pharmaceutical industry and academic researchers, pharmaceutical managers and executives, healthcare clinicians, policymakers, regulators, and lobbyists with an interest in drug development. It is also an excellent textbook for students in pharmacy, science, and medicine courses.